Quantcast

Latest Stem cells Stories

2014-06-03 11:48:40

University of Colorado Denver At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials...

2014-06-02 23:09:54

Stem Cell Research Products Market says full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell therapies market to be $3.31 billion, for a total of $6.53 billion. Dallas, Texas (PRWEB) June 02, 2014 According to report “Stem Cell Research Products Market - Opportunities, Tools, and Technologies” as of 2014, several broad categories of stem cells exist, including:     Embryonic stem cells,...

2014-06-02 08:31:56

SACRAMENTO, Calif., June 2, 2014 /PRNewswire/ -- SynGen Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that Dr. William Gerber has been appointed CEO to replace co-founder and lead inventor Philip Coelho. Mr. Coelho, who will become the Chief Technical Officer (CTO) of SynGen, noted "Bud Barry, my business partner and...

2014-06-02 08:29:08

On August 1, 2013 The Company issued 75,000,000 million shares as part of a venture to open restaurants in association with South Of The Border Holdings, Inc.; 70 Million have been canceled and returned to the company treasury. SARASOTA, Fla., June ­­2, 2014 /PRNewswire/ -- Caribbean International Holdings (OTC: CIHN) announced today that 70 million of the 75 million shares issued by the Company as part of a venture in association with South Of The Border Holdings, has been...

2014-05-29 20:23:02

COSTA MESA, Calif., May 29, 2014 /PRNewswire/ -- DaVinci Biosciences, LLC announced today that their paper on "Human Prenatal Intestine Cells as a Valuable Source of Stem Cells and Epithelial Cells; Phenotypic and Functional Characterization" has been accepted for publication in the peer-reviewed journal CELL & TISSUE TRANSPLANTATION & THERAPY. With the current move by researchers and governments to reduce the use of animals in drug development and testing, scientists are...

2014-05-29 15:51:33

University of Chicago Medical Center Pinpointing cause of relapse could lead to better therapies A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug. In a correspondence published online May 28 in the New England Journal of Medicine, they show how the mutation triggers resistance. Their finding could guide development of...

light and stem cells repair teeth
2014-05-29 10:12:00

Brett Smith for redOrbit.com - Your Universe Online Researchers led by a team from Harvard University have successfully used a low-power laser to stimulate stem cell differentiation within the body, according to a study published on Wednesday by Science Translational Medicine. [ Watch the Video: What Are Stem Cells? ] The study team used a laser to stimulate dental stem cells and cause them to form dentin – the hard tissue that makes up the majority of a tooth. The study was also...

2014-05-29 08:30:21

SAN DIEGO, May 29, 2014 /PRNewswire/ -- ViaCyte, Inc., a regenerative medicine company focused on developing a cell replacement therapy for the treatment of patients with insulin-dependent diabetes, announced today that the Company has settled a patent dispute involving certain of the Company's definitive endoderm patents and patent applications. The dispute involved an appeal to the U.S. District Court by Asterias Biotherapeutics, Inc., (as assignee of Geron Corporation), which...

2014-05-28 16:26:41

Groundbreaking Nature Publication Describes Successful ZFN Driven Genome Editing in Long-Term Repopulating Stem Cells Necessary for Clinical Translation RICHMOND, Calif., May 28, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication in Nature of data demonstrating efficient zinc finger nuclease (ZFN)-mediated, targeted gene insertion that resulted in correction of the genetic defect in stem cells from an individual with X-linked severe combined...

2014-05-27 16:25:18

NEW YORK, May 27, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon, founder, and chief medical officer of Blue Horizon International (BHI) and Blue Horizon Charitable Foundation (BHCF), visited with orphaned children on a recent business trip to Abuja and Lagos in Nigeria. After touring the facility, meeting with the founder, and her staff, he also made a $1,000 donation to help the orphanage fulfill its vision to provide shelter for abandoned and...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'